Intervention not reported
Serious adverse events · adolescent girls and women aged 15 to 45 years regardless of HPV DNA status at baseline
The intervention showed no clear difference in serious adverse events (high certainty).
1 finding from 1 review
- Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors 2018 · Cochrane Headline outcomes onlyRR 0.98 [0.92, 1.05]23 studies · 71597 participantsHigh